WA
Consensus Narrative from 1 Analyst
Focusing On Presbyopia Treatments May Open New Markets But Faces Competition And Economic Uncertainties
Key Takeaways Strategic investments in new clinics and geographic diversification aim to drive revenue growth while mitigating regional economic risks. Expansion into lens-based treatments and potential M&A activities position EuroEyes for revenue and earnings enhancement through market growth and strategic partnerships.
View narrativeHK$5.80
FV
45.3% undervalued intrinsic discount5.34%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
3 days ago author updated this narrative